About US
- HOME
- About US
Greetings from the CEO
The bodies of living organisms are composed of extremely sophisticated mechanisms, and what I have learned in my 30 years of research is that “You should ask living organisms about living organisms”. This is also true in drug discovery. If we screen directly in animals, we can efficiently obtain drugs that are effective from the start. The knowledge and technology we have cultivated in the field of developmental engineering research over a long period of time have led to the creation of an unprecedented high-resolution drug screening technology. The drug discovery pipeline of Sky Pharma was born from this background.
Profile
CEO: Hideki Ando Ph.D.
- Affiliate Professor, Tohoku University Graduate School of Dentistry (in office)
- Associate Professor, Department of Medicine, Tokyo Medical University
- Project Associate Professor, Department of Life Science and Technology, Tokyo Institute of Technology
- Research Fellow, Brain Science Institute, Institute of Physical and Chemical Research (RIKEN)
- Assistant Professor, The University of Tokyo, Department of Medicine
Company Overview
| Company name | Sky Pharma Co., Ltd. |
|---|---|
| CEO (Founder) | Hideki Ando, Ph.D. |
| Address | [Main Office] Higashinihon Fudosan Sendai First Bldg. 1F, 6-1, Shimizukoji, Wakabayashi-ku, Sendai City, Miyagi, 984-0075, Japan [Joint Research Laboratory] Division of Oral Physiology, Department of Oral Function and Morphology, Tohoku University Graduate School of Dentistry. 4-1 Seiryo-machi, Aoba-ku, Sendai City, Miyagi, 980-8575, Japan |
| Phone | +81-22-398-6635 |
| Capital Stock | 90,000,000 JPY |
| Major Shareholders | MAKOTO Capital Co., Ltd. Digisearch and Advertising Inc. Minato Mirai Patent Firm |
| Business Details | Development of regenerative medicine products |
| Patent application | Japan Patent Application No. 2020-063994* [Title] Regenerative medicine for the nervous system Japan Patent Application No. 2020-063994* [Title] Regenerative medicine for the nervous system Japan Patent Application No. 2020-063996* [Title] Regenerative medicine for the nervous system Japan Patent Application No. 2020-063997* [Title] Screening method and manufacturing method for regenerative medicine of the nervous system WO 2021/201170 PCT/JP2021/014027 Japan Patent Application No. 2021-575899 [Title] Method for screening for, method for producing, and method for designing drug active ingredients https://patentscope.wipo.int/search/ja/detail.jsf?docId=WO2021201170&tab=PCTBIBLIO *Basis for an International application with a claim to priority under the Treaty of Paris. PC2954JP01 Japan Patent Application No.2023-189796 [Title] Recovery of locomotion and nervous system in spinal cord injured rat by administration of low molecular chemical agents identified by zebrafish screening |
Address
Joint Research Laboratory
Aobayama Laboratory
Collaboration and
Partnership
Inquiries
Contact the number below for inquiries regarding collaboration and partnership with Sky Pharma Co.,Ltd.
TEL 022-398-6635
Phone +81-22-398-6635
Businesses and
Products
Inquiries
Contact the number below for inquiries regarding the businesses and products of Sky Pharma Co.,Ltd.
TEL 022-398-6635
Phone +81-22-398-6635